Material and behavioral financial hardship as predictors of health-related quality of life in a diverse cohort of cancer survivors.

Authors

null

Theresa A. Hastert

Karmanos Cancer Institute, Detroit, MI

Theresa A. Hastert , Felicity W. K. Harper , Jennifer Lynn Beebe-Dimmer , Tara Baird , Ann G. Schwartz

Organizations

Karmanos Cancer Institute, Detroit, MI, Wayne State University/Karmanos Cancer Institute, Detroit, MI, Barbara Ann Karmanos Cancer Institute, Detroit, MI

Research Funding

Other Foundation

Background: Financial hardship is common among cancer survivors, but its association with health-related quality of life (HRQOL) unknown. Methods: We utilized data from 570 black participants the Detroit Research on Cancer Survivors (ROCS) cohort study diagnosed with breast, colorectal, lung or prostate cancer since 1/1/13 and diagnosed or treated at the Karmanos Cancer Institute, and 402 white survivors meeting the same criteria. HRQOL was measured using the functional assessment of cancer therapy-general (FACT-G) and its subscales of physical, social, emotional and functional wellbeing, and site-specific measures. We fit linear regressions to estimate associations between material (debt, borrowing, selling assets, reduced income) and behavioral (skipping medication, not seeing a doctor, refusing treatment due to cost) financial hardship (MFH and BFH, respectively) and HRQOL. Adjusted models include demographic, socioeconomic, and treatment-related factors. Results: Overall, 50.3% of participants experienced material and 17.6% experienced behavioral financial hardship. In unadjusted models, HRQOL scores were 0.39 (95% CI 0.27, 0.51) standard deviations (SD) lower in those reporting any MFH. MFH was associated with significantly lower physical, emotional, and functional wellbeing scores, and with lower scores on breast-, colorectal-, and prostate-specific HRQOL measures. Total HRQOL was 0.68 SD (95% CI 0.52, 0.84) lower for participants who reported BFH than those who did not, and BFH was inversely associated with each subscale and each cancer-specific measure. In adjusted models, HRQOL scores were 0.15 (95% CI 0.03, 0.27) SD lower among participants reporting MFH and remained inversely associated with physical and functional wellbeing. BFH was associated with 0.42 (95% CI 0.27, 0.57) SD lower HRQOL scores and remained inversely associated with physical, social, emotional, and functional wellbeing; and with breast- and prostate-specific measures. Conclusions: MFH and BFH are associated with lower HRQOL among diverse cancer survivors. Addressing BFH in particular may improve HRQOL among survivors, particularly those with breast and prostate cancer.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Abstract Details

Meeting

2018 Cancer Survivorship Symposium

Session Type

Oral Abstract Session

Session Title

Oral Abstract Session A

Track

Care Coordination, Cost, and Education,Late- and Long-term Effects/Comorbidities,Health Promotion,Psychosocial Issues,Communication and Transitions,Risk Assessment,Chronic Anti-Cancer Therapy

Sub Track

Quality-of-Life Issues

Citation

J Clin Oncol 36, 2018 (suppl 7S; abstr 145)

DOI

10.1200/JCO.2018.36.7_suppl.145

Abstract #

145

Abstract Disclosures

Similar Abstracts

First Author: Lufan Wang

Abstract

2022 ASCO Quality Care Symposium

Surviving colorectal cancer: A study of information needs and health-related quality of life.

First Author: Lynette Hammond Gerido

Abstract

2024 ASCO Genitourinary Cancers Symposium

Endocrine and metabolic diseases among survivors of prostate cancer in a population-based cohort.

First Author: Siqi Hu